Posted on 26 March 2012.
A recent randomized study reports that using laser, instead of acid tyrode solution (ATZD), for zona pellucida drilling results in lesser embryo exposure during biopsy in preimplantation genetic diagnosis (PGD) cycles, and increases the availability of blastocysts for transfer and better treatment outcomes. Continue Reading
Posted in ART, Female Infertility, Genetics, IVF, IVF Outcome, Laboratory, Miscarriage, PGD, Technology
Posted on 22 February 2012.
In order to avoid the first seven of the daily injections of FSH and the hypersensitivity or immune reactions due to this repetitive treatment, a single injection of corifollitropin alfa has been suggested for patients undergoing controlled ovarian stimulation (COS). Now, a multicentered phase III uncontrolled trial has reported that the use of 150 μg corifollitropin alfa in a standard GnRH antagonist protocol is safe and efficient, and has no effect on immunogenicity in normal responders undergoing up to three treatment cycles. Continue Reading
Posted in ART, Female Infertility, ICSI, IVF, IVF Outcome, Infertility, Miscarriage
Posted on 19 January 2012.
Obesity adversely affects the reproductive health of a woman as it is known to cause anovulation, menstrual irregularities, and infertility. However, the findings of various studies on the influence of BMI on controlled ovarian hyperstimulation factors, such as quantity of gonadotropin and days of stimulation required, oocyte quality/quantity, maximum level of estradiol, and success of pregnancy, are inconsistent. A recent prospective study reports that women with elevated BMI produce more follicles, and require fewer days of stimulation and gonadotropin during IVF treatment, although no significant effects on pregnancy outcome rates were reported. Continue Reading
Posted in ART, Female Infertility, Guidelines, IVF, IVF Outcome, Infertility, Miscarriage, Pregnancy
Posted on 04 December 2011.
Dehydroepiandrosterone (DHEA) is considered to increase the chances of pregnancy in women with decreased ovarian reserve (DOR), and is frequently used in nearly over a third of IVF centers worldwide. Adding credence to the currently available level II and III evidences, a comprehensive review and meta-analysis has reported that DHEA supplementation improves pregnancy chances in women with DOR. Continue Reading
Posted in Female Infertility, Fertility, IVF, IVF Outcome, Infertility, Menopause, Miscarriage, Pregnancy
Posted on 03 February 2011.
Low chromatin packaging quality in morphologically normal spermatozoa is one of the important factors that lower the fertilization capability of the sperm. Therefore, evaluating DNA integrity is essential to determine actual sperm fertility potential. A recent prospective study published in Fertility and Sterility provides new evidence that DNA integrity analysis using alkaline comet assay may be beneficial in diagnosing male infertility and predicting IVF outcomes. Continue Reading
Posted in ART, Diagnostics, Fertility, Guidelines, ICSI, IUI, IVF, IVF Outcome, Infertility, Male Infertility, Miscarriage, News, Pregnancy, Technology
Posted on 23 December 2010.
The results of a recent randomized, prospective, controlled study published in the journal, Human Reproduction, adds credence to the potential of dehydroepiandrosterone (DHEA) supplementation in enhancing IVF treatment outcomes in poor responders. Continue Reading
Posted in ART, Drugs, Female Infertility, Fertility, Fertility Preservation, Guidelines, IVF, IVF Outcome, Implantation, Infertility, Miscarriage, Pregnancy
Posted on 22 July 2010.
Crinone® vaginal gel, a natural progesterone supplementation approved by the U.S. FDA for women undergoing assisted reproduction, has better tolerability and comparable effectiveness to intramuscular progesterone (IMP) for luteal phase support during in vitro fertilization-embryo transfer (IVF-ET) cycles, according to the findings of a prospective randomized trial published in the online issue of the journal, Fertility and Sterility. Continue Reading
Posted in ART, Drugs, Female Infertility, IVF Outcome, Miscarriage
Posted on 08 May 2010.
A team of researchers has developed a breakthrough embryo screening technique termed molecular preimplantation genetic diagnosis (PGD), which uses a PCR-based protocol for analyzing translocations. The new approach, having the potential to identify more viable embryos for transfer, utilizes multiplexed short tandem repeat (STR) markers that are positioned on both segments of the translocated chromosomes during translocation analysis. The findings of the study have been published in the journal, Molecular Human Reproduction. Continue Reading
Posted in ART, Diagnostics, Embryology, Featured, Female Infertility, Genetics, Infertility, Laboratory, Miscarriage, News, PGD, Technology
Posted on 07 May 2010.
The prevalence of subclinical hypothyroidism (SH) is reported to be high in infertile women. Despite this, its management remains controversial owing to the lack of proven treatment benefits. Now, a recent prospective, randomized trial has highlighted the importance of levothyroxine (LT4) supplementation for achieving clinical pregnancies in women with SH opting for IVF-ICSI. The findings of the study have been published in the recent issue of Endocrine Practice. Continue Reading
Posted in ART, Diagnostics, Endocrinology, Female Infertility, Fertility, ICSI, IVF, IVF Outcome, Infertility, Laboratory, Miscarriage, Pregnancy, Technology
Posted on 07 April 2010.
In a recent prospective cohort study, a team of Danish researchers have reported that singleton IVF/ICSI pregnancies have a >4-fold enhanced risk of stillbirths compared to spontaneous conceptions. The results have been published in the recent issue of Human Reproduction. Continue Reading
Posted in ART, Fertility, ICSI, IVF, IVF Outcome, Infertility, Miscarriage, News, Pregnancy